As of January 22, 2025, Kodiak Sciences (KOD) has a market cap of $0.42 billion USD. According to our data, Kodiak Sciences is ranked No.6322 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.42 B |
-19.15%
|
Dec 31, 2024 | $0.52 B |
227.30%
|
Dec 29, 2023 | $0.16 B |
-57.54%
|
Dec 30, 2022 | $0.38 B |
-91.55%
|
Dec 31, 2021 | $4.46 B |
-42.29%
|
Dec 31, 2020 | $7.73 B |
104.18%
|
Dec 31, 2019 | $3.79 B |
913.38%
|
Dec 31, 2018 | $0.37 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Novartis
NVS
|
$196.25 B |
0.003 M
|
Switzerland
|
Bausch Health
BHC
|
$2.85 B |
6.423 M
|
Canada
|
Alcon
ALC
|
$43.91 B |
-0.001 M
|
Switzerland
|
Adverum Biotechnologies
ADVM
|
$93.20 M |
0.000 M
|
USA
|
Ocular Therapeutix
OCUL
|
$1.26 B |
-0.000 M
|
USA
|
Clearside Biomedical
CLSD
|
$73.95 M |
-0.000 M
|
USA
|
EyePoint Pharmaceuticals
EYPT
|
$0.60 B |
-0.000 M
|
USA
|
Outlook Therapeutics
OTLK
|
$51.06 M |
0.000 M
|
USA
|
Ginkgo Bioworks
DNA
|
$0.74 B |
0.158 B
|
USA
|
Kala Pharmaceuticals
KALA
|
$36.48 M |
-0.000 M
|
USA
|
Market Cap | = | KOD Stock Price | * | KOD Shares Outstanding |
= | $8.05 | * | 52.62 M | |
= | $0.42 B |